Home / General / US Supreme Court Backs Generic Drugmaker in ‘Skinny Label’ Patent Case

US Supreme Court Backs Generic Drugmaker in ‘Skinny Label’ Patent Case

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

By Blake Brittain
WASHINGTON, June 4 (Reuters) – The U.S. Supreme Court ruled ⁠on ⁠Thursday drugmaker Hikma’s generic version ⁠of Amarin Pharma’s cardiovascular medication Vascepa did not infringe Amarin’s patents, in a ​decision that may make generi… [2661 chars]

Source: U.S. News & World Report | Published: 2026-06-04T14:07:00Z

Credit: U.S. News & World Report

Tagged: